180 related articles for article (PubMed ID: 9328365)
21. Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis.
Thillet J; Faucher C; Issad B; Allouache M; Chapman J; Jacobs C
Am J Kidney Dis; 1993 Jul; 22(1):226-32. PubMed ID: 8322787
[TBL] [Abstract][Full Text] [Related]
22. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein (a) levels and clinical correlations in CAPD patients.
Lye WC; Hughes K; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():131-3. PubMed ID: 8534686
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
25. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
26. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
[TBL] [Abstract][Full Text] [Related]
30. Is atherosclerosis accelerated by CAPD?
Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O
Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197
[TBL] [Abstract][Full Text] [Related]
31. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
[TBL] [Abstract][Full Text] [Related]
32. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
Kimak E; Solski J
Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
[TBL] [Abstract][Full Text] [Related]
33. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.
Trenkwalder E; Gruber A; König P; Dieplinger H; Kronenberg F
Kidney Int; 1997 Dec; 52(6):1685-92. PubMed ID: 9407518
[TBL] [Abstract][Full Text] [Related]
34. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
Anwar N; Bhatnagar D; Short CD; Mackness MI; Durrington PN; Prais H; Gokal R
Nephrol Dial Transplant; 1993; 8(1):71-4. PubMed ID: 8381941
[TBL] [Abstract][Full Text] [Related]
35. Elevated plasma lipoprotein(a) levels and hypoalbuminemia in peritoneal dialysis patients.
Ross EA; Shah GM; Kashyap ML
Int J Artif Organs; 1995 Dec; 18(12):751-6. PubMed ID: 8964640
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting low values of serum albumin in CAPD patients.
Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
[TBL] [Abstract][Full Text] [Related]
37. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
[TBL] [Abstract][Full Text] [Related]
39. Reduced oxidative stress in hypoalbuminemic CAPD patients.
Kim SB; Yang WS; Min WK; Lee SK; Park JS
Perit Dial Int; 2000; 20(3):290-4. PubMed ID: 10898045
[TBL] [Abstract][Full Text] [Related]
40. Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients.
Kim SB; Chi HS; Park JS; Hong CD; Yang WS
Am J Kidney Dis; 1999 Feb; 33(2):312-7. PubMed ID: 10023644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
